Hepatic Arterial Infusion for Biliary Tract Carcinoma: Single-center Experience

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F13%3A33145193" target="_blank" >RIV/61989592:15110/13:33145193 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11150/13:10195440 RIV/00179906:_____/13:10195440

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Hepatic Arterial Infusion for Biliary Tract Carcinoma: Single-center Experience

Original language description

Aim: The aim of the present study was to evaluate a single-center experience in hepatic arterial infusion (HAI) of patients with biliary tract carcinomas. Patients and Methods: A retrospective analysis of 60 patients treated between 1997 and 2011 was performed. Results: Most patients were treated with HAI of a combination of 5-fluorouracil, folinic acid and cisplatin. The response was not evaluable in most patients, predominantly because of prior surgical procedures. The median survival of all patientswas 15.1 months (5-year survival=13%). The survival was significantly better in patients treated with radical surgery (median=50.1 months, 5-year survival=45%) or palliative surgery (median=22.5 months, 5-year survival=13%) compared to no surgery (median=7.6 months, 5-year survival=3%). Conclusion: The current data demonstrate the efficacy of HAI in patients with biliary tract carcinoma. HAI is a therapeutic method to be considered in patients with inoperable biliary tract carcinoma and

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/ED0030%2F01%2F01" target="_blank" >ED0030/01/01: Biomedicine for regional development and human resources</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Anticancer Research

ISSN

0250-7005

e-ISSN

—

Volume of the periodical

33

Issue of the periodical within the volume

3

Country of publishing house

GR - GREECE

Number of pages

7

Pages from-to

1201-1207

UT code for WoS article

—

EID of the result in the Scopus database

—